Comparative study of the humoral immune responses developed by 5 commercial monovalent <i>Erysipelothrix rhusiopathiae</i> vaccines

Inicio Conocimiento Comparative study of the humoral immune responses developed by 5 commercial monovalent <i>Erysipelothrix rhusiopathiae</i> vaccines

Comparative study of the humoral immune responses developed by 5 commercial monovalent <i>Erysipelothrix rhusiopathiae</i> vaccines

The aim of this study was to compare the humoral immune responses elicited in naïve pigs by five different inactivated monovalent Erysipelothrix rhusiopathiae vaccines.

Sobre este artículo

Apareció en

IPVS Congress, 2016

Autores

Camprodon, A.; Pedrazuela, R.; Torrents, D.

Resumen

In this study, the humoral immunity elicited by ERYSENG® was faster, higher and lasted longer than the humoral immune response developed by the other commercial vaccines. ERYSENG® provided the best humoral protection during the entire fattening period.

Servicios relacionados

Productos relacionados

Compartir en